Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Longmore, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Edvinsson, L; Sams, A; Jansen-Olesen, I; Tajti, J; Kane, SA; Rutledge, RZ; Koblan, KS; Hill, RG; Longmore, J
      Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries

      EUROPEAN JOURNAL OF PHARMACOLOGY
    2. Hasbak, P; Sams, A; Schifter, S; Longmore, J; Edvinsson, L
      CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (W098/11128), a non-peptide antagonist

      BRITISH JOURNAL OF PHARMACOLOGY
    3. Hou, MY; Kanje, M; Longmore, J; Tajti, J; Uddman, R; Edvinsson, L
      5-HT1B and 5-HT1D receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase

      BRAIN RESEARCH
    4. Uddman, R; Longmore, J; Cardell, LO; Edvinsson, L
      Expression of 5-HT1B receptors in human nasal mucosa

      ACTA OTO-LARYNGOLOGICA
    5. Hargreaves, RJ; Longmore, J; Beer, M; Shepheard, S; Cumberbatch, M; Williamson, D; Stanton, J; Razzaque, Z; Sohal, B; Street, L; Seabrook, G; Hill, R
      The pharmacology and mechanisms of action of rizatriptan

      DRUG TREATMENT OF MIGRAINE AND OTHER HEADACHES
    6. Bock, MG; Longmore, J
      Bradykinin antagonists: new opportunities

      CURRENT OPINION IN CHEMICAL BIOLOGY
    7. Longmore, J; Maguire, JJ; MacLeod, A; Street, L; Schofield, WN; Hill, RG
      Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptoragonist L-775,606 with the mixed 5-HT1B/(1D)-receptor agonist sumatriptan and 5-HT in human isolated coronary artery

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    8. Olivar, T; Razzaque, Z; Nwagwu, M; Longmore, J
      Neurogenic vasodilation in rabbit basilar isolated artery: involvement of calcitonin-gene related peptide

      EUROPEAN JOURNAL OF PHARMACOLOGY
    9. Razzaque, Z; Heald, MA; Pickard, JD; Maskell, L; Beer, MS; Hill, RG; Longmore, J
      Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    10. Nilsson, T; Longmore, J; Shaw, D; Pantev, E; Bard, JA; Branchek, T; Edvinsson, L
      Characterisation of 5-HT receptors in human coronary arteries by molecularand pharmacological techniques

      EUROPEAN JOURNAL OF PHARMACOLOGY
    11. Nilsson, T; Longmore, J; Shaw, D; Olesen, IJ; Edvinsson, L
      Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry

      BRITISH JOURNAL OF PHARMACOLOGY
    12. Bonafini, L; Thomas, SR; Hill, RG; Longmore, J
      beta-amyloid inhibits endothelial-dependent relaxations in rabbit isolatedaorta: An interaction between superoxide radicals and nitric oxide?

      ALZHEIMERS REPORTS
    13. Longmore, J; Razzaque, Z; Shaw, D; Davenport, AP; Maguire, J; Pickard, JD; Schofield, WN; Hill, RG
      Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    14. ANDERSEN MT; LONGMORE J; LIEFTING LW; WOOD GA; SUTHERLAND PW; BECK DL; FORSTER RLS
      PHORMIUM YELLOW LEAF PHYTOPLASMA IS ASSOCIATED WITH STRAWBERRY LETHALYELLOWS DISEASE IN NEW-ZEALAND

      Plant disease
    15. SMITH D; SHAW D; HOPKINS R; MCALLISTER G; HILL R; SIRINATHSINGHJI D; LONGMORE J
      DEVELOPMENT AND CHARACTERIZATION OF HUMAN 5-HT1B-RECEPTOR OR 5-HT1D-RECEPTOR SPECIFIC ANTIBODIES AS UNIQUE RESEARCH TOOLS

      Journal of neuroscience methods
    16. LONGMORE J; SHAW D; SMITH D; HOPKINS R; MCALLISTER G; PICKARD JD; SIRINATHSINGHJI DJS; BUTLER AJ; HILL RG
      DIFFERENTIAL DISTRIBUTION OF 5HT(1D)-IMMUNOREACTIVITY AND 5HT(1B)-IMMUNOREACTIVITY WITHIN THE HUMAN TRIGEMINO-CEREBROVASCULAR SYSTEM - IMPLICATIONS FOR THE DISCOVERY OF NEW ANTIMIGRAINE DRUGS

      Cephalalgia
    17. SANTAGATI A; LONGMORE J; GUCCIONE S; LANGER T; TONNEL E; MODICA M; SANTAGATI M; SCOLARO LM; RUSSO F
      BUILDING A MODEL OF INTERACTION AT THE NK-2 RECEPTORS - POLYCONDENSEDHETEROCYCLES CONTAINING THE PYRIMIDOINDOLE SKELETONS

      European journal of medicinal chemistry
    18. LONGMORE J; RAZZAQUE Z; SCHOFIELD WN; TAYLOR AA; BROWN MJ; PICKARD J; HILL RG; HARGREAVES RJ
      RIZATRIPTAN SHOWS CRANIOVASCULAR SELECTIVITY FOR HUMAN ISOLATED MIDDLE MENINGEAL OVER CORONARY-ARTERIES - A COMPARISON WITH SUMATRIPTAN

      Neurology
    19. LONGMORE J; HILL RG; HARGREAVES RJ
      NEUROKININ-RECEPTOR ANTAGONISTS - PHARMACOLOGICAL TOOLS AND THERAPEUTIC DRUGS

      Canadian journal of physiology and pharmacology
    20. RAZZAQUE Z; SHAW D; SMITH D; HOPKINS R; SIRINATHSINGHJI D; MASKELL L; STANTON JA; BEER MS; HILL RG; PICKARD J; LONGMORE J
      PHARMACOLOGICAL ANALYSIS OF 5-HT-RECEPTOR-MEDIATED VASOCONSTRICTION OF HUMAN MIDDLE MENINGEAL ARTERIES - DETERMINING THE CONTRIBUTION OF 5-HT1B AND 5-HT1F RECEPTOR ACTIVATION

      British Journal of Pharmacology
    21. STERNFELD F; BAKER R; BROUGHTON HB; GUIBLIN AR; JELLEY RA; MATASSA VG; REEVE AJ; BEER MS; STANTON JA; HARGREAVES RJ; SHEPHEARD SL; LONGMORE J; RAZZAQUE Z; GRAHAM MI; SOHAL B; STREET LJ
      THE CHEMICAL EVOLUTION OF 2-[5-(1,2,4-TRIAZOL-4-YL)-1H-INDOL-3-YL]ETHYLAMINE (L-741,604) AND ANALOGS - POTENT AND SELECTIVE AGONISTS FOR 5-HT1D RECEPTORS

      Bioorganic & medicinal chemistry letters
    22. GUCCIONE S; MODICA M; LONGMORE J; SHAW D; BARRETTA GU; SANTAGATI A; SANTAGATI M; RUSSO F
      SYNTHESIS AND NK-2 ANTAGONIST EFFECT OF -PYRAZOLO[3,4-D]-THIAZOLO[3,2-A]4H-PYRIMIDIN-4-ONE

      Bioorganic & medicinal chemistry letters
    23. LONGMORE J; BOULANGER CM; DESTA B; HILL RG; SCHOFIELD WN; TAYLOR AA
      5-HT1D RECEPTOR AGONISTS AND HUMAN CORONARY-ARTERY REACTIVITY IN-VITRO - CROSSOVER COMPARISONS OF 5-HT AND SUMATRIPTAN WITH RIZATRIPTAN ANDL-741,519

      British journal of clinical pharmacology
    24. SHAW D; STANTON JA; HEALD MA; BEER MS; STERNFELD F; STREET L; HILL RG; COOKE E; LONGMORE J
      IN-VITRO ASSESSMENT OF THE VASCULAR EFFECTS OF 5-HT1D-RECEPTOR AGONISTS - RELATIONSHIPS WITH 5-HT1D-ALPHA-RECEPTOR OR 5-HT1D-BETA-RECEPTOR BINDING-AFFINITY

      British Journal of Pharmacology
    25. RAZZAQUE Z; BAKER R; BEER MS; HILL RG; MATASSA VG; STAGG AT; STERNFELD F; STREET L; LONGMORE J
      IN-VITRO PHARMACOLOGICAL EFFECTS OF 2 NOVEL 5-HT1D-RECEPTOR AGONISTS L-741,519 AND L-741,604 - COMPARISON WITH SUMATRIPTAN AND BW311C

      British Journal of Pharmacology
    26. ASONGANYI B; BORKOWSKI J; HESS JF; SHAW D; HILL RG; LONGMORE J
      INDUCTION OF B-1-RECEPTOR-MEDIATED FUNCTIONAL-RESPONSES IN MOUSE URINARY-BLADDER - EFFECTS OF GENETIC DEPLETION OF THE B-2-RECEPTOR GENE

      British Journal of Pharmacology
    27. FERRO A; LONGMORE J; HILL RG; BROWN MJ
      A COMPARISON OF THE CONTRACTILE EFFECTS OF 5-HYDROXYTRYPTAMINE, SUMATRIPTAN AND MK-462 ON HUMAN CORONARY-ARTERY IN-VITRO

      British journal of clinical pharmacology
    28. HUTSON PH; BRISTOW LJ; CUNNINGHAM JR; HOGG JE; LONGMORE J; MURRAY F; PEARCE D; RAZZAQUE Z; SAYWELL K; TRICKLEBANK MD; YOUNG L
      THE EFFECTS OF GR127935, A PUTATIVE 5-HT1D RECEPTOR ANTAGONIST, ON BRAIN 5-HT METABOLISM, EXTRACELLULAR 5-HT CONCENTRATION AND BEHAVIOR IN THE GUINEA-PIG

      Neuropharmacology
    29. RAZZAQUE Z; LONGMORE J; HILL RG
      DIFFERENCES IN THE EFFECTS OF KETANSERIN AND GR127935 ON 5-HT-RECEPTOR MEDIATED RESPONSES IN RABBIT SAPHENOUS-VEIN AND GUINEA-PIG JUGULAR-VEIN

      European journal of pharmacology
    30. BOULANGER CM; LONGMORE J; DESTA B; SCHOFIELD W; HILL RG; TAYLOR AA
      FURTHER-STUDIES ON THE RESPONSE OF HUMAN CORONARY-ARTERIES TO THE 5-HT1D RECEPTOR AGONISTS SUMATRIPTAN AND MK-462

      British Journal of Pharmacology
    31. FERRO A; LONGMORE J; HILL RG; BROWN MJ
      A COMPARISON OF THE CONTRACTILE EFFECTS OF 5-HT, SUMATRIPTAN AND MK-462 ON HUMAN CORONARY-ARTERY IN-VITRO

      British Journal of Pharmacology
    32. LONGMORE J; HOGG JE; HUTSON PH; HILL RG
      EFFECTS OF 2 TRUNCATED FORMS OF HUMAN CALCITONIN-GENE-RELATED PEPTIDE- IMPLICATIONS FOR RECEPTOR CLASSIFICATION

      European journal of pharmacology
    33. LONGMORE J; RAZZAQUE Z; SHAW D; HILL RG
      DIFFERENCES IN THE EFFECTS OF NK1-RECEPTOR ANTAGONISTS, (PLUS-OR-MINUS)-CP-96,345 AND CP-99,994, ON AGONIST-INDUCED RESPONSES IN GUINEA-PIGTRACHEA

      British Journal of Pharmacology
    34. RAZZAQUE Z; LONGMORE J; HILL RG
      DIFFERENCES IN THE EFFECTS OF KETANSERIN ON 5-HT-RECEPTOR-MEDIATED RESPONSES IN RABBIT SAPHENOUS-VEIN AND GUINEA-PIG JUGULAR-VEIN

      British Journal of Pharmacology
    35. LONGMORE J; FONG TM; HILL RG
      THE SUSCEPTIBILITY OF AGONIST-EVOKED RESPONSES TO ANTAGONISM BY (+ -)CP96345 AND RP67580 DIFFERS FOR HUMAN AND RAT CLONED NK1 RECEPTORS/

      British Journal of Pharmacology
    36. TAN KKC; BROWN MJ; LONGMORE J; PLUMPTON C; HILL RG
      DEMONSTRATION OF THE NEUROTRANSMITTER ROLE OF CALCITONIN-GENE-RELATEDPEPTIDES (CGRP) BY IMMUNOBLOCKADE WITH ANTI-CGRP MONOCLONAL-ANTIBODIES

      British Journal of Pharmacology
    37. TOTA MR; DANIEL S; SIROTINA A; MAZINA KE; FONG TM; LONGMORE J; STRADER CD
      CHARACTERIZATION OF A FLUORESCENT SUBSTANCE-P ANALOG

      Biochemistry
    38. RAZZAQUE Z; LONGMORE J
      COMPARISON OF THE EFFECTS OF (+ -) CP 96,345 AND L-668,169 ON NEUROKININ RECEPTOR-MEDIATED RESPONSES IN RAT AND GUINEA-PIG ISOLATED-TISSUES/

      Neuropeptides
    39. SEABROOK GR; MAIN MJ; RAZZAQUE Z; LONGMORE J
      DIFFERENCES IN THE EFFECTS OF TACHYKININ NK(1) RECEPTOR ANTAGONISTS -NEURONAL VERSUS SMOOTH-MUSCLE TISSUES

      European journal of pharmacology
    40. RUPNIAK NMJ; BOYCE S; WILLIAMS AR; COOK G; LONGMORE J; SEABROOK GR; CAESER M; IVERSEN SD; HILL RG
      ANTINOCICEPTIVE ACTIVITY OF NK(1) RECEPTOR ANTAGONISTS - NONSPECIFIC EFFECTS OF RACEMIC RP67580

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 17/01/21 alle ore 13:29:25